Siringometaplasia escamosa ecrina en una niña tratada con quimioterapia

Actas Dermo-Sifiliograficas

Volumn 91, Issue 1-2, 2000, Pages 34-36

  Cerro, Marta Del ^a   Torrelo, Antonio ^a   Madero, Luis ^a   Mediero, Imelda G ^a   Zambrano, Antonio ^a  

^a NONE

Author keywords

[No Author keywords available]

Indexed keywords

EID: 0042229454     PISSN: 00017310     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (19)

1. Serrano T, Sáez A, Moreno A. Eccrine squamous syringometaplasia. A prospective clinicopathologic study. J Cutan Pathol 1993;20:61-5.
2. Metcalf JS, Maize JC. Squamous syringometaplasia in lobular panniculitis and pyoderma gangrenosum. Am J Dermatopathol 1990;12:141-9.
3. Valks R, Buezo GF, Dauden E, Fraga J, García Díez A. Eccrine squamous syringometaplasia in intertriginous areas. Br J Dermatol 1996; 134:984-6.
4. Caputo R, Monti M, Ermacora E, et al. Cutaneous manifestations of tetrachloro-dibenzo-p-dioxin in children and adolescents. J Am Acad Dermatol 1988;19:812-9.
5. Helton JL, Metcalf JS. Squamous syringometaplasia in association with annular elastolytic granuloma. Am J Dermatopathol 1995;17:407-9.
6. Bhawan J, PetryJ, Rybak ME. Histologic changes induced in skin by extravasation of doxorubicin (adriamycin). J Cutan Pathol 1989;16:158-63.
7. Santa Cruz D, Samuels LE, Bauer EA, et al. Epidermal distrophy: clinicopathologic study of chemotherapeutic agent toxicity in ten patients. Lab Invest 1982;46:72 (abstract).
8. Flynn TC, Harrist TJ, Murphy GF, Loss RW Moschella S. Neutrophilic eccrine hidradenitis: a distinctive rash associated with cytarabine therapy and acute leukemia. J Am Acad Dermatol 1984; 11:584-90.
9. Bhawan J, Malhotra R. Syringosquamous metaplasia. A distinctive eruption in patients receiving chemotherapy. Am J Dermatopathol 1990;12:l-6.
10. Hurt MA, Halvorson RD, Petr FC, Cooper JT, Friedman DJ. Eccrine squamous syringometaplasia. A cutaneous sweet gland reaction in the histologic spectrum of «chemotherapy-associated eccrine hidradenitis» and «neutrophilic eccrine hidradenitis». Arch Dermatol 1990; 126:73-7.
11. Jones M, Fraga J, SánchezJ, Fernández, García A. Siringometaplasia escamosa ecrina. Actas Dermosifiliogr 1990; 81:825-7.
12. Rongioletti F, Ballestrero A, Bogliolo F, Rebora A. Necrotizing eccrine squamous syringometaplasia presendng as acral erythema. J Cutan Pathol 1991; 18:453-6.
13. Kanwar VS, Gajjar A, Ribeiro RC, et al. Unusual cutaneous toxicity following treatment with dactinomycin: a report of two cases. Med Pediatr Oncol 1995;24:329-33.
14. Ríos L, Peñas PF, Dauden E, et al. Recall phenomenon with the unusual presence of eccrine squamous syringometaplasia. Br J Dermatol 1995;133:630-2.
15. Valks R, Fraga J, Porras-Luque J, et al. Chemotherapy-induced eccrine squamous syringometaplasia. A distinctive eruption in patients receiving hematopoietic progenitor cells. Arch Dermatol 1997;133:873-8.
16. Harrist TJ, Fine JD, Berman RS, Murphy GF, Mihm MC. Neutrophilic eccrine hidradenitis. A distinctive type of neutrophilic dermatosis associated with myelogenous leukemia and chemotherapy. Arch Dermatol 1982; 118:263-6.
17. Scallan S, Kettler PJ, Levy ML, Tschen JA. Neutrophilic eccrine hidradentitis: evidence implicating bleomycin as a causative agent. Cancer 1988;62:2532-6.
18. Horn TD. Antineoplastic chemotherapy, sweat and the skin. Arch Dermatol 1997; 133:905-6.
19. Horn TD, Beveridge RA, Egorin MJ, Abeloff MD, Hood AF. Observations and proposed mechanism of N, N', N-triethylenethiophosphoramide (thiotepa)-induced hyperpigmentation. Arch Dermatol 1989; 125:524-7.